Aclaris Therapeutics Inc.

NASDAQ: ACRS · Real-Time Price · USD
1.88
0.19 (11.24%)
At close: Aug 15, 2025, 3:59 PM
1.83
-2.40%
After-hours: Aug 15, 2025, 07:57 PM EDT

Aclaris Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-1.45 -0.83 -11.82 -9.08
PEG Ratio
-0.04 0.18 0.70 -0.27
PS Ratio
10.24 2.35 34.52 122.00
PB Ratio
1.23 0.47 5.20 4.18
P/FCF Ratio
-9.49 -0.92 -15.07 -15.73
P/OCF Ratio
-9.55 -0.94 -15.2 -15.82
OCF/S Ratio
-1.07 -2.51 -2.27 -7.71
Debt / Equity Ratio
0.02 0.02 0.01 0.01
Quick Ratio
3.99 4.16 11.11 8.94
Current Ratio
3.99 4.16 10.55 8.94
Asset Turnover
0.08 0.16 0.12 0.03
Interest Coverage
n/a n/a -19.12 n/a
Return on Equity
-0.85 -0.56 -0.44 -0.46
Return on Assets
-0.6 -0.45 -0.34 -0.36
Return on Invested Capital
-0.75 -0.58 -0.39 -0.36
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.85 0.42 0.60 0.30
Net Profit Margin
-7.05 -2.83 -2.92 -13.44
Pretax Profit Margin
-7.05 -2.84 -2.92 -13.44
Operating Profit Margin
-7.58 -3.12 -3.02 -9.67
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-2.76 -2.82 -2.84 -9.53